Healio Rheumatology Current Issue

The following articles appeared in the print edition of Healio Rheumatology.

Table of Contents

• Next gen physicians: Rheumatology fellows optimistic for ‘happier’ specialty Rob Volansky
• The future of rheumatology: Searching for joy Leonard H. Calabrese, DO
• Almost 10% of women infected during pregnancy develop long COVID Erin T. Welsh, MA
• Diabetes, weight loss drugs emerging as treatment pathway in rheumatology Justin Cooper
• FDA approves IND application for Eque-cel T-cell therapy in SLE, lupus nephritis
• FDA grants fast track designation to cyclobenzaprine tablets for fibromyalgia
• Growing armamentarium means ‘we have options’ for ANCA-associated vasculitis Rob Volansky
• Healio Rheumatology wins APEX award for story on ‘moral imperative’ to address burnout Rob Volansky
• IFN signature in lupus endotypes may lead to ‘targeted and personalized’ treatments Rob Volansky
• Implications of the Federal Trade Commission noncompete ban, what physicians need to know Sanjeev Bhatia, MD; David B. Mandell, JD, MBA
• Knowing ‘fluid’ nature of axial spondyloarthritis critical to preventing serious outcomes Rob Volansky
• Long-term exercise program improves physical function in axial SpA beyond ‘usual care’ Justin Cooper
• MACE, malignancies rarer in Latin American patients with rheumatoid arthritis Justin Cooper
• Monitoring nightmares, hallucinations ‘extremely valuable’ in lupus, early flare treatment Rob Volansky
• Nurse-developed protocol ‘greatly aided’ COVID-19 treatment Rob Volansky
• ‘On the cusp of a new era’: Promising drugs may tackle unmet needs in giant cell arteritis Rob Volansky
• Over 90% of hospitalized COVID-19 patients have lung lesions 2 years following discharge Isabella Hornick
• Renal, cardiovascular risks lower in patients with lupus using metformin Justin Cooper
• Rheum for Debate: Have biosimilars reduced drug costs for patients? Rob Volansky
• SGLT2 inhibitors slash risks for lupus nephritis, heart failure in SLE, type 2 diabetes Justin Cooper
• ‘Silver tsunami’ likely to have significant impacts for rheumatology providers Rob Volansky
• Though common in rheumatology, lymphadenopathy may be ‘hallmark’ of serious, rare disease Justin Cooper
• TNF inhibitors equally safe, effective in young- and late-onset ankylosing spondylitis Justin Cooper
• Training the ‘inner voice to be kind’ critical for young patients with rheumatic diseases Rob Volansky
• US Supreme Court decision on mifepristone ‘not a victory, but a punt’ Rob Volansky